Pellet vs. FDA approved Hormonal Therapy in postmenopausal women: Preliminary safety findings from a retrospective cohort study

Authors

Xuezhi Jiang, Reading Hospital - Tower HealthFollow
Peter Schnatz, Reading Hospital - Tower HealthFollow
K A. Matson
B Desai
S Walker
S Corcoran
P Lau
A Cochran
L Damon Jr
J Larkin
Mark B. Woodland, Reading Hospital - Tower HealthFollow

Document Type

Poster Presentation

Publication Date

10-11-2017

Publication Title

28th NAMS Annual Meeting

Recommended Citation

Jiang, X., Schnatz, P., Matson, K. A., Desai, B., Walker, S., Corcoran, S., Lau, P., Cochran, A., Damon, L., Larkin, J., & Woodland, M. B. (2017). Pellet vs. FDA approved Hormonal Therapy in postmenopausal women: Preliminary safety findings from a retrospective cohort study. 28th NAMS Annual Meeting Retrieved from https://scholarcommons.towerhealth.org/gme_ob_gyn_res_read/16